ORIGINAL RESEARCH
Accepted on 09 Oct 2025
International cost-effectiveness analysis in osimertinib after chemoradiotherapy in stage III EGFR-mutated non-small cell lung cancer
doi 10.3389/fpubh.2025.1698562
- 230 views
- Frontiers in Public Health
- Health Economics
- Research Topics
- Health Economic Evaluation in Cancer Prevention and Control
Health Economic Evaluation in Cancer Prevention and Control
1,618
Total downloads
5,486
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 09 Oct 2025
Cost-effectiveness analysis of cabozantinib plus atezolizumab for advanced hepatocellular carcinoma
doi 10.3389/fphar.2025.1556304
- 667 views
REVIEW
Accepted on 29 Sep 2025
Cost Analysis and Cost-Effectiveness of Traditional Chinese Medicine in Lung Cancer: A Scoping Review
doi 10.3389/fpubh.2025.1669751
- 385 views
ORIGINAL RESEARCH
Published on 11 Sep 2025
Global, regional, and national disease burden and economic costs of cervical cancer (1991–2021): a multidimensional data synthesis analysis
doi 10.3389/fpubh.2025.1633975
- 1,115 views
ORIGINAL RESEARCH
Published on 14 Aug 2025
Cost-utility of endoscopic screening strategies for upper gastrointestinal cancer across China: a modeling study
doi 10.3389/fpubh.2025.1643171
- 856 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.